TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Pharmadule Morimatsu AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
75,822
|
43,558
|
21,011 |
Financial expenses |
2,349
|
13,372
|
2,595 |
Earnings before taxes |
2,702
|
1,482
|
2,413 |
EBITDA |
1,249
|
-1,291
|
1,234 |
Total assets |
35,706
|
27,639
|
26,914 |
Current assets |
35,518
|
26,360
|
26,710 |
Current liabilities |
27,147
|
21,369
|
21,451 |
Equity capital |
8,252
|
6,102
|
5,368 |
- share capital |
180
![]() |
180
|
196 |
Employees (average) |
14
![]() |
14
![]() |
14 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
23.1%
|
22.1%
|
19.9% |
Turnover per employee |
5,416
|
3,111
|
1,501 |
Profit as a percentage of turnover |
3.6%
|
3.4%
|
11.5% |
Return on assets (ROA) |
14.1%
|
53.7%
|
18.6% |
Current ratio |
130.8%
|
123.4%
|
124.5% |
Return on equity (ROE) |
32.7%
|
24.3%
|
45.0% |
Change turnover |
32,137
|
24,249
|
14,284 |
Change turnover % |
74%
|
126%
|
212% |
Chg. No. of employees |
0
![]() |
0
|
1 |
Chg. No. of employees % |
0%
![]() |
0%
|
8% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.